I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| epithelial cell | 3 studies | 20% ± 2% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| epithelial cell | 3 studies | 20% ± 2% |
Insufficient scRNA-seq data for expression of CHPF2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| stomach | 100% | 2542.48 | 359 / 359 | 100% | 51.96 | 286 / 286 |
| lung | 100% | 3096.46 | 578 / 578 | 100% | 65.75 | 1154 / 1155 |
| skin | 100% | 4022.40 | 1809 / 1809 | 100% | 83.79 | 470 / 472 |
| ovary | 100% | 2234.03 | 180 / 180 | 100% | 55.64 | 428 / 430 |
| esophagus | 100% | 2179.97 | 1445 / 1445 | 99% | 53.95 | 182 / 183 |
| intestine | 100% | 2627.81 | 966 / 966 | 99% | 54.50 | 524 / 527 |
| breast | 100% | 2378.51 | 457 / 459 | 100% | 59.39 | 1116 / 1118 |
| thymus | 100% | 3090.40 | 652 / 653 | 100% | 53.54 | 602 / 605 |
| prostate | 100% | 3135.09 | 245 / 245 | 99% | 56.91 | 498 / 502 |
| adrenal gland | 100% | 4681.22 | 258 / 258 | 99% | 76.84 | 228 / 230 |
| uterus | 100% | 2698.53 | 170 / 170 | 99% | 51.02 | 455 / 459 |
| bladder | 100% | 2618.57 | 21 / 21 | 99% | 54.05 | 499 / 504 |
| kidney | 100% | 2019.27 | 89 / 89 | 99% | 44.06 | 889 / 901 |
| pancreas | 100% | 2335.78 | 328 / 328 | 98% | 63.69 | 175 / 178 |
| liver | 99% | 1551.92 | 223 / 226 | 92% | 26.39 | 372 / 406 |
| brain | 86% | 1054.71 | 2282 / 2642 | 99% | 39.06 | 697 / 705 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 41.69 | 29 / 29 |
| spleen | 100% | 4481.14 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 39.66 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 18.54 | 1 / 1 |
| adipose | 100% | 2235.31 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 3716.28 | 1333 / 1335 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 99% | 36.88 | 79 / 80 |
| heart | 98% | 1973.26 | 841 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 97% | 2974.58 | 901 / 929 | 0% | 0 | 0 / 0 |
| muscle | 71% | 725.05 | 569 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0030206 | Biological process | chondroitin sulfate biosynthetic process |
| GO_0000139 | Cellular component | Golgi membrane |
| GO_0032580 | Cellular component | Golgi cisterna membrane |
| GO_0016020 | Cellular component | membrane |
| GO_0050510 | Molecular function | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity |
| GO_0047238 | Molecular function | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity |
| Gene name | CHPF2 |
| Protein name | Chondroitin polymerizing factor 2 Chondroitin sulfate glucuronyltransferase (EC 2.4.1.226) (CSGlcA-T) (Chondroitin glucuronyltransferase) (Chondroitin polymerizing factor 2) (ChPF-2) (Chondroitin synthase 3) (ChSy-3) (N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase) Hexosyltransferase (EC 2.4.1.-) |
| Synonyms | tcag7.785 CSGLCAT UNQ299/PRO339 CSGlcA-T hCG_18696 KIAA1402 CHSY3 |
| Description | FUNCTION: Transfers glucuronic acid (GlcUA) from UDP-GlcUA to N-acetylgalactosamine residues on the non-reducing end of the elongating chondroitin polymer. Has no N-acetylgalactosaminyltransferase activity. . |
| Accessions | A0A8I5KUJ5 ENST00000465601.2 ENST00000692651.1 C9JZF7 ENST00000685322.1 A0A8I5KSK8 H7C5L5 ENST00000690577.1 ENST00000035307.7 [Q9P2E5-1] ENST00000482173.6 ENST00000495645.5 G5E9W2 A0A8I5KRN5 Q9P2E5 ENST00000689322.1 |
